Biomolecular mechanism of urinary stone formation involving osteopontin. - Wikidata - wikimedia - TriplyDB

Biomolecular mechanism of urinary stone formation involving osteopontin.

Biomolecular mechanism of urinary stone formation involving osteopontin.

http://www.wikidata.org/entity/Q38057623

about

Pathophysiology-based treatment of urolithiasis.Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria.Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques Unified theory on the pathogenesis of Randall's plaques and plugs Hydration status affects osteopontin expression in the rat kidney.Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition.M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development.Histological aspects of the "fixed-particle" model of stone formation: animal studies.The role of macromolecules in the formation of kidney stones.Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition.Genome-Wide Gene Expression Profiling of Randall's Plaques in Calcium Oxalate Stone Formers.c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors.Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region.

P2860

Q30248402-8396CA90-6093-48C1-9CE8-2B6DF779F952 Q33701562-305E9452-D16E-43CA-933E-E832ECAA317B Q34857373-DF3E7BDD-DA5E-4A12-A30F-9E9368C31662 Q35216521-F2579E73-489F-4519-BB6B-032DBD7E5971 Q35863103-5715E821-63D4-489C-B1BD-1C67F66D5C31 Q37164533-BAB74FE2-225F-42DA-A050-336BCCC3506F Q37330448-C6441F46-4C8C-4ECD-8DE5-002BA01F84D0 Q39023117-333E9D9C-1D1D-4219-81B5-DA000BE8D88F Q39028115-2BFA5B6F-1DED-468B-B14B-A636B3B5B2BB Q43438637-28D701D9-6B12-4614-8F41-62AFA5456661 Q47103946-9122A0A8-99D7-44EC-9017-0FFA4E60F3C6 Q50128482-D9F87942-7960-4C7C-BEC3-4E030F7D9F4B Q51734597-E056002A-BCC5-4864-B4C3-F9CE5E76A5DF

P2860

Biomolecular mechanism of urinary stone formation involving osteopontin.

http://www.wikidata.org/entity/Q38057623

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Biomolecular mechanism of urinary stone formation involving osteopontin.

@en

type

label

Biomolecular mechanism of urinary stone formation involving osteopontin.

@en

prefLabel

Biomolecular mechanism of urinary stone formation involving osteopontin.

@en

P1433

Q38057623-CE3C87D7-E785-4C32-9151-24ACEEE8AC20

P1476

Q38057623-0B321807-2A17-409E-ACA8-90FCFAC154BF

P2093

Q38057623-471164A9-991C-4DE5-B878-732F399F0457

Q38057623-8C4C99B3-48E9-4F89-962D-04EB83E53F3C

Q38057623-B2B52CFB-9048-4B2B-A409-07EFBCD3633B

Q38057623-C5C8CC77-5D81-459C-8608-00047B68D167

Q38057623-DA30C735-E30D-4F5A-90F5-00FBF34DC672

Q38057623-DC600378-3357-4CF5-ABFA-66707278F86C

Q38057623-E99C85E5-1241-4396-9F2D-0B63B959FB94

Q38057623-F34C2E6B-6E66-4F6B-AF63-8C13E0AE323E

P2860

Q38057623-0494E466-734F-4883-8BC0-E7566896E460

Q38057623-05B574E2-733C-4E6A-A6E0-DBCA601E0D25

Q38057623-09DD85B3-D998-457F-A9EB-F80A7B3F74D8

Q38057623-0C6C7A5A-E549-458B-BE43-B3EA8692FE92

Q38057623-11C73BE2-08B5-4753-A6A6-35282098B52D

Q38057623-18C4F8AE-AEC3-4C0A-B78C-FACE03B2CC51

Q38057623-2089B17C-3B0E-48B2-ACC6-DAC87FD5B51B

Q38057623-22309906-5A43-41C2-A5F8-1E6836762477

Q38057623-23DF1C32-17E1-4279-8009-82202BFB9E76

Q38057623-30E0F018-8A0B-44AC-B729-ED697DEB8EC5

P304

Q38057623-BD5AD566-8002-4323-927B-9E24322C020C

P31

Q38057623-28A1FC7D-39D6-4412-B4A0-26812F76A9F5

P356

Q38057623-24E37B57-6281-4B0B-843D-386C5D5ABE47

P433

Q38057623-0ADB63F5-FF0E-428D-A7BC-9E8B0BEFF4E4

P478

Q38057623-211AAE10-35D3-433D-B3DF-AFCA56558F7D

P577

Q38057623-13004D95-10D5-4759-8B0D-004085C8E962

P698

Q38057623-D693B698-B631-401D-A9B7-76706734EB66

P356

S00240-012-0514-Y

P1433

Urological Research

P1476

Biomolecular mechanism of urinary stone formation involving osteopontin.

@en

P2093

Atsushi Okada

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Niimi

http://www.w3.org/2001/XMLSchema#string

Kazumi Taguchi

http://www.w3.org/2001/XMLSchema#string

Kenjiro Kohri

http://www.w3.org/2001/XMLSchema#string

Masahito Hirose

http://www.w3.org/2001/XMLSchema#string

Shuzo Hamamoto

http://www.w3.org/2001/XMLSchema#string

Takahiro Yasui

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Fujii

http://www.w3.org/2001/XMLSchema#string

P2860

Roles of electrostatics and conformation in protein-crystal interactions

Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning

Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi

Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence

Three pathways for human kidney stone formation

Adiponectin and adiponectin receptors

Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin.

Bone mineral density measurement in patients with recurrent normocalciuric calcium stone disease.

1,2,3,4,6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model

Calcium and bone metabolism during space flight.

P304

623-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00240-012-0514-Y

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23124115

http://www.w3.org/2001/XMLSchema#string